SGI-1027
SIGMA/SML1358 - ≥98% (HPLC)
Synonym: N-
CAS Number: 1020149-73-8
Empirical Formula (Hill Notation): C27H23N7O
Molecular Weight: 461.52
MDL Number: MFCD27937047
Linear Formula: C27H23N7O
Product Type: Chemical
assay | ≥98% (HPLC) |
color | white to light brown |
form | powder |
InChI | 1S/C27H23N7O/c1-17-16-25( |
InChI key | QSYLKMKIVWJAAK-UHFFFAOYSA |
Quality Level | 100 |
SMILES string | O=C(NC1=CC=C(NC2=NC(N)=NC |
solubility | DMSO: 20 mg/mL, clear |
storage temp. | 2-8°C |
Application: | SGI-1027 has been used as a DNA methyltransferase inhibitor to study its effects on gene expression during osteogenic differentiation. It has also been used as a DNA methyltransferase 3a inhibitor to study its effects on interleukin-6 (IL-6)-induced loss of forkhead box P3 (Foxp3) gene expression in B-lymphocyte-induced maturation protein 1 (Blimp1)-Treg cells. |
Biochem/physiol Actions: | SGI-1027 is a DNA methyltransferase (DNMT) inhibitor with IC50 values of 6-13 μM for DNMT3B, DNMT3A and DNMT1. SGI-1027 directly inhibits DNMT activity by competing with the cofactor, S-adenosylmethionine (SAM) in the methylation reaction. SGI-1027 treatment of cancer cell lines induced degradation of DNMT1, but not DNMT3A or DNMT3B, and in RKO cells caused re-expression of the silenced tumor supressor genes p16, MLH1 and TIMP3. |
Packaging: | 5, 25 mg in glass bottle |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Purity | ≥98% (HPLC) |
Storage Temp. | 2-8°C |
UNSPSC | 12352200 |